Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

HIV Drug ResistanceHIV Drug Resistance
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


What are my options
Jan 30, 2007

Im in Australia and have a fantastic doctor. he has spoken of the possibility of once a week ijections and of systems that will allow drugs to be blown through the skin. I have CD4 of about 400 and Undetectable VL...I am 42 and so keen to make it to 52 and beyond. What are my options should Fuezon fail or become resistant. i am resistant to most other drugs.Thanks

Response from Ms. Salisbury

Hi Australia, You have many options. Fuzeon is a bridge to keep you healthy until the new drugs become available. There should be at least 2 new classes of HIV meds available soon. These include the entry inhibitors and the integrase inhibitors.

The once a week option is currently being studied, I am not sure when it will be available. It would be a great plus for giving a great drug such as Fuzeon to patients who are reluctant to inject twice a day. Keep the faith. Carol


Previous
cure or treatment?
Next
natural fusion inhibitors

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement